Registered entities
VERALOX THERAPEUTICS INC.
Reg. No. 82-3072071United States
Innovation
6 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 29 times.
| Year | Filings |
|---|---|
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 6 |
| 2026 | 2 |
Investor mix
15 investors on record; lead investors include Hatteras Venture Partners, Sanofi Ventures, T1D Fund, VTC Innovation Fund.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 67% |
| Angel & family office | 1 | 7% |
| Other / undisclosed | 4 | 27% |